PRME Latest Headlines

Prime Medicine’s Advancements and Financial Strength Support Buy Rating Amid Promising Developments in Gene Editing and Rare Diseases

at www.tipranks.com (Tue, 4-Mar 12:55 AM)

J.P. Morgan Reaffirms Their Buy Rating on Prime Medicine, Inc. (PRME)

at www.tipranks.com (Mon, 3-Mar 7:11 AM)

Prime Medicine, Inc.: Promising Gene Editing Developments and Strong Financial Position Justify Buy Rating

at www.tipranks.com (Mon, 3-Mar 6:36 AM)

Prime Medicine GAAP EPS of -$1.65 misses by $0.30, revenue of $2.98M misses by $3.4M

at seekingalpha.com (Mon, 3-Mar 3:38 AM)

Prime Medicine Reports 2024 Financial Results and Progress

at www.tipranks.com (Fri, 28-Feb 11:11 PM)

TD Cowen Sticks to Its Buy Rating for Prime Medicine, Inc. (PRME)

at www.tipranks.com (Fri, 28-Feb 9:37 AM)